Mebhydrolin
RESPIRATORY SYSTEM
Also known as: diazolinum, fabahistin, mebhydrolin napadisilate, mebhydrolin napadisylate, mebhydroline
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Mebhydrolin is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1954. DrugCentral lists 4 molecular targets, including HRH1, HTR5A and CHRM1. Recorded indications include Allergic rhinitis.
- Molecular targets: HRH1, HTR5A, CHRM1 and HRH4 (4 listed in DrugCentral).
- Indications: Allergic rhinitis.
- ATC code: R06AX15 (Other antihistamines for systemic use).
- Molecular formula: C19H20N2; molecular weight 276.38 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Allergic rhinitis
Mechanism & targets
Molecular targets (4)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Histamine H1 receptor | HRH1 | antagonist | Ki 7.12 |
| 5-hydroxytryptamine receptor 5A | HTR5A | unknown | Ki 6.92 |
| Muscarinic acetylcholine receptor M1 | CHRM1 | unknown | Ki 6.75 |
| Histamine H4 receptor | HRH4 | unknown | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1954-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
R06AX15 | RESPIRATORY SYSTEM › ANTIHISTAMINES FOR SYSTEMIC USE › ANTIHISTAMINES FOR SYSTEMIC USE › Other antihistamines for systemic use |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Mebhydrolin is on its molecule page.
| Molecular formula | C19H20N2 |
|---|---|
| Molecular weight | 276.38 g/mol |
| CAS number | 524-81-2 |
| InChIKey | FQQIIPAOSKSOJM-UHFFFAOYSA-N |
| PubChem CID | 22530 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Mebhydrolin used for?
DrugCentral lists the following indications for Mebhydrolin: Allergic rhinitis.
How does Mebhydrolin work?
Its molecular targets in DrugCentral include HRH1 (antagonist), HTR5A, CHRM1 and HRH4.
When was Mebhydrolin first approved?
Mebhydrolin was first approved by the YEAR INTRODUCED in 1954.
What is the chemical formula of Mebhydrolin?
Mebhydrolin has the molecular formula C19H20N2 and a molecular weight of 276.38 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1643 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1625607 — compound record and bioactivity
- PubChem CID 22530 — chemical identifiers
- DrugBank DB13808 — drug record
- FDA UNII 9SUK9B7XVY — substance identity
- UniProt P35367 (HRH1) — target protein
- UniProt P47898 (HTR5A) — target protein
- UniProt P11229 (CHRM1) — target protein
- UniProt Q9H3N8 (HRH4) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.